Literature DB >> 10975842

Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes.

K Maenaka1, T Maenaka, H Tomiyama, M Takiguchi, D I Stuart, E Y Jones.   

Abstract

The crystal structures of the human MHC class I allele HLA-B*5101 in complex with 8-mer, TAFTIPSI, and 9-mer, LPPVVAKEI, immunodominant peptide epitopes from HIV-1 have been determined by x-ray crystallography. In both complexes, the hydrogen-bonding network in the N-terminal anchor (P1) pocket is rearranged as a result of the replacement of the standard tyrosine with histidine at position 171. This results in a nonstandard positioning of the peptide N terminus, which is recognized by B*5101-restricted T cell clones. Unexpectedly, the P5 peptide residues appear to act as anchors, drawing the peptides unusually deeply into the peptide-binding groove of B51. The unique characteristics of P1 and P5 are likely to be responsible for the zig-zag conformation of the 9-mer peptide and the slow assembly of B*5101. A comparison of the surface characteristics in the alpha1-helix C-terminal region for B51 and other MHC class I alleles highlights mainly electrostatic differences that may be important in determining the specificity of human killer cell Ig-like receptor binding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975842     DOI: 10.4049/jimmunol.165.6.3260

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution.

Authors:  Alessandro Sette; John Sidney; Brian D Livingston; John L Dzuris; Claire Crimi; Christopher M Walker; Scott Southwood; Edward J Collins; Austin L Hughes
Journal:  Immunogenetics       Date:  2003-02-14       Impact factor: 2.846

2.  Long-term control of HIV-1 in hemophiliacs carrying slow-progressing allele HLA-B*5101.

Authors:  Yuka Kawashima; Nozomi Kuse; Hiroyuki Gatanaga; Takuya Naruto; Mamoru Fujiwara; Sachi Dohki; Tomohiro Akahoshi; Katsumi Maenaka; Philip Goulder; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

3.  A biochemical and structural analysis of genetic diversity within the HLA-A*11 subtype.

Authors:  Lenong Li; Weifeng Chen; Marlene Bouvier
Journal:  Immunogenetics       Date:  2005-05-04       Impact factor: 2.846

4.  Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides.

Authors:  Daniel Gebreselassie; Hans Spiegel; Stanislav Vukmanovic
Journal:  Hum Immunol       Date:  2006-09-20       Impact factor: 2.850

5.  Purification, crystallization and preliminary X-ray diffraction analysis of the human major histocompatibility antigen HLA-B*2703 complexed with a viral peptide and with a self-peptide.

Authors:  Bernhard Loll; Anna Zawacka; Jacek Biesiadka; Christine Rückert; Armin Volz; Wolfram Saenger; Barbara Uchanska-Ziegler; Andreas Ziegler
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-03-12

6.  Two distinct conformations of a rinderpest virus epitope presented by bovine major histocompatibility complex class I N*01801: a host strategy to present featured peptides.

Authors:  Xin Li; Jun Liu; Jianxun Qi; Feng Gao; Qirun Li; Xiaoying Li; Nianzhi Zhang; Chun Xia; George F Gao
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

7.  Redundancy and Complementarity between ERAP1 and ERAP2 Revealed by their Effects on the Behcet's Disease-associated HLA-B*51 Peptidome.

Authors:  Pablo Guasp; Elena Lorente; Adrian Martín-Esteban; Eilon Barnea; Paolo Romania; Doriana Fruci; JonasJ W Kuiper; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2019-05-15       Impact factor: 5.911

8.  The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing.

Authors:  Pablo Guasp; Eilon Barnea; M Francisca González-Escribano; Anaïs Jiménez-Reinoso; José R Regueiro; Arie Admon; José A López de Castro
Journal:  J Biol Chem       Date:  2017-04-26       Impact factor: 5.157

9.  HLA-B*59:01: a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese.

Authors:  F Yang; J Xuan; J Chen; H Zhong; H Luo; P Zhou; X Sun; L He; S Chen; Z Cao; X Luo; Q Xing
Journal:  Pharmacogenomics J       Date:  2015-04-28       Impact factor: 3.550

10.  HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions.

Authors:  Y Yang; S Chen; F Yang; L Zhang; G Alterovitz; H Zhu; J Xuan; X Yang; H Luo; J Mu; L He; X Luo; Q Xing
Journal:  Pharmacogenomics J       Date:  2016-08-16       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.